Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.
Authorities allege the pharmacy chain gave patients more insulin than prescribed and then billed Medicare and Medicaid for the full amounts. This allegedly occurred for more than a decade.
The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.
The Massachusetts senator is asking buyer Sycamore Partners for certain assurances, including that it won’t saddle the struggling pharmacy chain with even more debt and indiscriminately close retail locations.
Ontario-based Andlauer Healthcare Group ships sensitive temperature-controlled products necessary for healthcare manufacturing and research. It has agreed to be acquired by the world’s largest courier, with the all-cash deal expected to close later this year.
The pharmacy chain was accused of filling “millions” of unlawful prescriptions for opioids and other controlled substances. Despite agreeing to the payout, the company does not admit wrongdoing.
The two companies have been unable to assuage antitrust concerns raised by the Department of Justice. A magistrate will attempt to hammer out acceptable terms for the home healthcare merger at a conference scheduled for August.